Novo Nordisk A/S (B) Yahoo! Finance
| Spread | 3.49 | Spread (%) | 0.50% |
|---|---|---|---|
| Overnight funding - Buy | -0.05676% | Overnight funding - Sell | -0.03108% |
| Initial margin | 20.00% | Maintenance margin | 10.00% |
| Leverage | 1:5 | Expires daily | No |
| Name | Sell | Sell button / Change | Buy | Change | ||
|---|---|---|---|---|---|---|
| {{item.Name}} | {{item.SellPrice}} | Sell | {{item.BuyPrice}} | Buy | {{item.ChangePercentText}} | Trade |
Moderna and Pfizer, two of the biggest names in the biotech industry, are expected to release Q3 2023 earnings in the coming days.
Read More
This article delves into the possible market effects of Novo Nordisk's diabetes drug, Ozempic, and shows how stocks have been reacting in response.
Read More
The stock market ended its first half of 2021 on a positive note, with the S&P 500 hitting its fifth consecutive record high.
Read MorePlus500 uses cookies to improve your browsing experience. You can click "Accept" or continue browsing to consent to cookies usage.
Hi! You've reached our website for customers based outside of the United States.
Make the move to Plus500US in order to start your Futures trading journey!
